Market Overview:
The global onychomycosis treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of onychomycosis, growing awareness about available treatments, and rising demand for better and faster-acting therapies. The medication segment is expected to dominate the global onychomycosis treatment market in terms of revenue during the forecast period. This can be attributed to the high adoption rate of oral antifungal drugs and rising prevalence of fungal nail infections. However, the lasers segment is projected to grow at a higher CAGR during the forecast period owing to technological advancements in laser technology that are making it easier for clinicians to target specific areas infected with fungi and improve patient outcomes. In terms of application, hospitals are expected to account for the largest share of revenue in 2018 followed by dermatology clinics.
Product Definition:
Onychomycosis Treatment is the use of medications, nails fungus laser treatment or surgery to treat a fungal infection of the fingernails or toenails.
Medication:
Onychomycosis is a fungal infection of the nail. It's major symptom includes brittle nails that easily break and become discolored. Onychomycosis can affect any individual but it mostly affects people aged between 20 to 60 years. The prevalence rate of onychomycosis in North America is 2% and it increases with age, thus making an individual more susceptible to this disease.
Lasers:
Laser is a tool that produces light for the treatment of various medical conditions. The light beam used in laser treatments is usually generated by a diode or from an optical fiber. Diode lasers produce red and green lights, which are more effective in treating different types of skin diseases like acne, rosacea, etc. Optical fibers are flexible tubes made up of glass or plastic that guide the light to where it needs to be with high accuracy.
Application Insights:
The dermatology clinics segment dominated the market for onychomycosis treatment and held the largest revenue share in 2017. The high prevalence of diabetes, especially type 1, is a major factor contributing to the growth of this segment. Moreover, an increase in diabetic patients leads to an increased risk of fungal infections including onychomycosis which can be treated at dermatology clinics. Thus rising number of patients suffering from onychomycosis has led to an increased demand for treatment at dermatology clinics which is expected to drive growth over the forecast period.
On the other hand, hospitals are estimated to witness lucrative CAGR during the study period owing to increasing incidence rate.
Regional Analysis:
North America dominated the global onychomycosis treatment market in 2017. The presence of a large number of manufacturers, availability of effective treatment methods, and high patient awareness levels are some factors attributing to its largest share. Moreover, rising incidence rates due to increased exposure to fungus-infected environments is expected to further drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing disposable income and growing consumer awareness regarding available treatments for onychomycosis. Furthermore, an increase in healthcare expenditure by governments along with rising investments by major pharmaceutical companies will boost revenue generation in this region over the next eight years.
Growth Factors:
- Increasing incidence of onychomycosis
- Growing awareness about onychomycosis and its treatment options
- Rising demand for effective and safe onychomycosis treatments
- Technological advancements in onychomycosis treatment methods
- Growing number of research and development activities focused on Onychomycosis Treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Onychomycosis Treatment Market Research Report
By Type
Medication, Lasers, Photodynamic Therapy
By Application
Hospitals, Dermatology Clinics, Retail Pharmacies, Online Pharmacies
By Companies
Pfizer, Novartis, Johnson & Johnson, Bausch Health, Bayer, Lumenis, Galderma, Moberg Pharma, Cipla, Biofrontera, Leo Pharma, Dr. Reddy's Laboratories, Medimetriks Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Onychomycosis Treatment Market Report Segments:
The global Onychomycosis Treatment market is segmented on the basis of:
Types
Medication, Lasers, Photodynamic Therapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dermatology Clinics, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis
- Johnson & Johnson
- Bausch Health
- Bayer
- Lumenis
- Galderma
- Moberg Pharma
- Cipla
- Biofrontera
- Leo Pharma
- Dr. Reddy's Laboratories
- Medimetriks Pharmaceuticals
Highlights of The Onychomycosis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Medication
- Lasers
- Photodynamic Therapy
- By Application:
- Hospitals
- Dermatology Clinics
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Onychomycosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for onychomycosis will vary depending on the individual's symptoms and medical history. However, some common treatments for onychomycosis include topical creams or ointments that kill the fungus, oral antibiotics to treat the infection, and surgery to remove infected areas of skin.
Some of the major players in the onychomycosis treatment market are Pfizer, Novartis, Johnson & Johnson, Bausch Health, Bayer, Lumenis, Galderma, Moberg Pharma, Cipla, Biofrontera, Leo Pharma, Dr. Reddy's Laboratories, Medimetriks Pharmaceuticals.
The onychomycosis treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Onychomycosis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Onychomycosis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Onychomycosis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Onychomycosis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Onychomycosis Treatment Market Size & Forecast, 2018-2028
4.5.1 Onychomycosis Treatment Market Size and Y-o-Y Growth
4.5.2 Onychomycosis Treatment Market Absolute $ Opportunity
Chapter 5 Global Onychomycosis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Onychomycosis Treatment Market Size Forecast by Type
5.2.1 Medication
5.2.2 Lasers
5.2.3 Photodynamic Therapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Onychomycosis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Onychomycosis Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Dermatology Clinics
6.2.3 Retail Pharmacies
6.2.4 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Onychomycosis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Onychomycosis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Onychomycosis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Onychomycosis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Onychomycosis Treatment Market Size Forecast by Type
9.6.1 Medication
9.6.2 Lasers
9.6.3 Photodynamic Therapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Onychomycosis Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Dermatology Clinics
9.10.3 Retail Pharmacies
9.10.4 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Onychomycosis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Onychomycosis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Onychomycosis Treatment Market Size Forecast by Type
10.6.1 Medication
10.6.2 Lasers
10.6.3 Photodynamic Therapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Onychomycosis Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Dermatology Clinics
10.10.3 Retail Pharmacies
10.10.4 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Onychomycosis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Onychomycosis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Onychomycosis Treatment Market Size Forecast by Type
11.6.1 Medication
11.6.2 Lasers
11.6.3 Photodynamic Therapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Onychomycosis Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Dermatology Clinics
11.10.3 Retail Pharmacies
11.10.4 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Onychomycosis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Onychomycosis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Onychomycosis Treatment Market Size Forecast by Type
12.6.1 Medication
12.6.2 Lasers
12.6.3 Photodynamic Therapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Onychomycosis Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Dermatology Clinics
12.10.3 Retail Pharmacies
12.10.4 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Onychomycosis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Onychomycosis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Onychomycosis Treatment Market Size Forecast by Type
13.6.1 Medication
13.6.2 Lasers
13.6.3 Photodynamic Therapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Onychomycosis Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Dermatology Clinics
13.10.3 Retail Pharmacies
13.10.4 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Onychomycosis Treatment Market: Competitive Dashboard
14.2 Global Onychomycosis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Novartis
14.3.3 Johnson & Johnson
14.3.4 Bausch Health
14.3.5 Bayer
14.3.6 Lumenis
14.3.7 Galderma
14.3.8 Moberg Pharma
14.3.9 Cipla
14.3.10 Biofrontera
14.3.11 Leo Pharma
14.3.12 Dr. Reddy's Laboratories
14.3.13 Medimetriks Pharmaceuticals
